Biogen
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Biogen generated cash of $1,547,200,000, which is more than the previous year. Cash used in financing activities reached the amount of $149,300,000 last year. Net change in cash is therefore -$2,369,400,000.
Cash Flow
| 2014 | 2.94B | -1.54B | -755.87M |
|---|---|---|---|
| 2015 | 3.71B | -4.55B | 986.4M |
| 2016 | 4.52B | -2.48B | -987.8M |
| 2017 | 4.55B | -2.96B | -2.38B |
| 2018 | 6.18B | -2.04B | -4.47B |
| 2019 | 7.07B | 470.5M | -5.86B |
| 2020 | 4.22B | -608.6M | -5.27B |
| 2021 | 3.63B | -563.7M | -2.08B |
| 2022 | 1.38B | 1.57B | -1.75B |
| 2023 | 1.54B | -4.10B | 149.3M |
BIIB Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.41B | 2.26B | 1.33B | 2.91B | 1.22B | 1.57B | 2.32B | 1.30B | 1.20B | 602.56M |
Operating activities | ||||||||||
Net income | 1.16B | 2.96B | 1.72B | 4.06B | 5.88B | 4.47B | 2.67B | 3.69B | 3.59B | 2.94B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 494.8M | 518.4M | 487.7M | 457.2M | 680.6M | 1.01B | 1.08B | 682.7M | 600.4M | 688.15M |
Stock-based compensation expense | 264.2M | 254.1M | 238.6M | 198.3M | 182.3M | 0 | 128M | 154.8M | 161.4M | 155.30M |
| Deferred income tax benefit | 264.2M | 254.1M | 238.6M | 198.3M | 182.3M | 0 | 128M | 154.8M | 161.4M | 155.30M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -203.4M | 324.8M | 2.8M | 68.8M | -205.2M | -435.6M | -241.4M | 29M | -512.38M |
Inventories | 0 | -320.2M | -462.4M | -316.3M | -19.2M | -52.1M | -94.5M | -165.6M | -174.4M | -185.91M |
Accounts payable | 0 | 0 | -94.2M | 330.9M | 133.6M | 335.8M | -538.4M | 712.6M | -523.7M | 149.86M |
Cash generated by operating activities | 1.54B | 1.38B | 3.63B | 4.22B | 7.07B | 6.18B | 4.55B | 4.52B | 3.71B | 2.94B |
Investing activities | ||||||||||
Purchases Of Investments | -5.14B | -3.44B | -3.80B | -6.83B | -5.25B | -8.15B | -5.35B | -7.91B | -6.86B | -3.58B |
Investments In Property Plant And Equipment | 277M | -243.2M | -294.9M | -551.8M | -669.5M | -886.1M | -1.96B | -727.7M | -643M | -287.75M |
Acquisitions Net | -6.13B | 990.3M | 28.1M | -565.5M | -120.7M | -2.17B | -1.2B | -1.2B | -1.04B | -375M |
Cash generated by investing activities | -4.10B | 1.57B | -563.7M | -608.6M | 470.5M | -2.04B | -2.96B | -2.48B | -4.55B | -1.54B |
Financing activities | ||||||||||
Common Stock Issued | -44.3M | -1.9M | -700K | -4.6M | 0 | -2.1M | 0 | 43.7M | 54.2M | 54.88B |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -750M | -1.8B | -6.67B | -5.86B | -4.35B | -1.36B | -1B | -5B | -886.77M |
Repayments of term debt | 187.3M | -1.00B | -170M | -1.5B | 0 | -3.2M | -560.9M | -2.7M | 5.92B | -2.67M |
Cash used in financing activities | 149.3M | -1.75B | -2.08B | -5.27B | -5.86B | -4.47B | -2.38B | -987.8M | 986.4M | -755.87M |
Net Change In Cash | -2.36B | 1.15B | 930.2M | -1.58B | 1.68B | -349.2M | -752.7M | 1.01B | 103.1M | 602.36M |
Cash at end of period | 1.04B | 3.41B | 2.26B | 1.33B | 2.91B | 1.22B | 1.57B | 2.32B | 1.30B | 1.20B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |